Company: EHC
Filing Date: 2025-04-01
Form Type: DEF 14A
Source: 0000785161-25-000013
Chunk: 13

Company: Encompass Health Corp
Filing Date: 2025-04-01
Form: DEF 14A
Chunk 13
---
ominating/Corporate Governance Committee                                         |     | 10/1/2021   |
| Nancy M. Schlichting*             |     |  70 |     | Member of Compensation and Human Capital Committee and Compliance and Quality of Care Committee (Chair)                 |     | 12/11/2017  |
| Mark J. Tarr                      |     |  63 |     | President and Chief Executive Officer                                                                                   |     | 12/29/2016  |
| Terrance Williams*                |     |  56 |     | Member of Audit Committee                                                                                               |     | 1/1/2020    |
| *   Denotes independent director. |     |     |     |                                                                                                                         |     |             |

There are no arrangements or understandings known to us between any of the nominees listed above and any other person pursuant to which that person was or is to be selected as a director or nominee, other than any arrangements or understandings with persons acting solely as directors or officers of Encompass Health.

<div align='center'>9</div>

All of the director nominees have public company, senior leadership and strategic planning experience and financial literacy. The following matrix is intended to summarize the other primary experiences, skills, and qualifications of the nominees. Each nominee’s individual experiences and qualifications are described in more detail in the biographies below.

<div align='center'>10</div>

| Joan E. Herman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 Ms. Herman has served as the president and chief executive officer of Herman & Associates, LLC, a healthcare and management consulting firm, since 2008. Herman & Associates provides services to healthcare providers, pharmacy benefit managers, managed care organizations, and private equity firms. From 1998 to 2008, she served in a number of senior management positions, including president and chief executive officer for two corporate divisions, at Elevance, Inc. (f/k/a Anthem, Inc. and WellPoint, Inc.), a leading managed healthcare company that offers network-based managed care plans. Prior to joining Elevance, she served in a number of senior positions at Phoenix Life Insurance Company for 16 years, lastly as senior vice president of strategic development. She currently serves as a director and a member of the audit, compensation, and compliance committees of Ionis Pharmaceuticals, Inc., an RNA-targeted drug discovery and development firm. She also serves on the boards of two Fifth Avenue Private Equity funds. 
 Ms. Herman has extensive experience leading